Adenoma Clinical Trial
Official title:
Comparison of Adenoma Detection and Miss Rates at Colonoscopy Associated With a Six-minute Withdrawal Time vs a Three-minute Withdrawal Time
The objective of this study is to determine the optimal withdrawal time for colonoscopy. A 6-minute withdrawal time is currently the standard of care but has only been evaluated in an observational fashion. The investigators believe that this should be validated in a standardized fashion. If the benefits of a 6 minute withdrawal are proven in this study (ie a low polyp/adenoma miss rate and a high polyp/adenoma detection rate), then this will support widespread adoption of a 6 minute withdrawal as the standard of care. This in turn may decrease the occurence of 'interval colon cancers', which are early colon cancers arising in subjects despite their having undergone colonoscopy. Our hypothesis is that the polyp/adenoma detection rate will be unacceptably low and the polyp/adenoma miss rate will be unacceptably high in the 3-minute withdrawal group when compared to the 6-minute withdrawal group.
Eligible patients will be randomized to colonoscopy with either a 6-minute withdrawal time or a 3-minute withdrawal time. Patients will then undergo colonoscopy. All colonoscopies will be performed by a GI attending (standard of care). The colonoscopy is typically performed under conscious sedation using medications such as fentanyl and midazolam for comfort (standard of care). Occasional patients undergo colonoscopy under general anesthesia. For all patients, advancement of the colonoscope to the cecum will be followed by segmental withdrawal of the colonoscope in each of 3 segments of the examined colon (right side of colon, transverse colon and left side of colon). Following examination of each individual segment, the colonoscope will be readvanced to the proximal end of the segment and a 2 minute withdrawal will be re-performed. For those randomized to the 6-minute withdrawal each segment will be examined over 2 minutes, followed by a "second look" over each segment over 2 minutes by the same endoscopist. For those randomized to the 3-minute withdrawal time, advancement to the cecum will also be followed by segmental withdrawal in each of 3 segments of the examined colon. Each segment will be examined over 1 minute, followed by a "second look" over each segment over 2 minutes by the same endoscopist. All patients will therefore undergo a second look colonoscopy with a 6-minute withdrawal time ('de-facto' standard of care). Polyp/adenoma detection and miss rates will then be calculated and compared between the two groups. ;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Recruiting |
NCT02545699 -
Prospective Trial to Compare ADR of G-EYE™ Colonoscopy With Standard Colonoscopy
|
N/A | |
Recruiting |
NCT01211132 -
Cap Assisted Colonoscopy for the Detection of Colon Polyps
|
N/A | |
Completed |
NCT04287335 -
Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China
|
||
Not yet recruiting |
NCT06398418 -
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
|
Phase 1 | |
Recruiting |
NCT05362344 -
Colorectal Cancer Screening in Cystic Fibrosis
|
||
Completed |
NCT03268200 -
The Effect of Segmental Re-examination of Colon for Adenoma Detection in Colonoscopy
|
N/A | |
Recruiting |
NCT04591145 -
Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System
|
||
Completed |
NCT02978664 -
The Impact of Distraction on Adenoma Detection Rate
|
N/A | |
Completed |
NCT00018551 -
Chemoprevention With Folic Acid
|
Phase 2 | |
Recruiting |
NCT05594576 -
Comparison of the ENDOCUFF VISION® Endoscopy Cap Coupled With GI GENIUS™ Artificial Intelligence Compared to Each Device Alone in Improving Colonic Adenoma Detection Rate During Colonoscopy
|
N/A | |
Not yet recruiting |
NCT04135716 -
A Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy
|
N/A | |
Recruiting |
NCT02288962 -
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
|
Phase 3 | |
Recruiting |
NCT02552017 -
Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities
|
N/A | |
Completed |
NCT02066064 -
G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different Endoscopist
|
N/A | |
Completed |
NCT01749722 -
Safety and Efficacy of the NaviAid™ G-Eye System During Colonoscopy
|
N/A | |
Completed |
NCT01485133 -
Water Method Colonoscopy in Patients With Prior Surgery
|
N/A | |
Withdrawn |
NCT01546259 -
Water Method in Low-body Mass Index (BMI) Female Patients With Unsedated Colonoscopy
|
N/A | |
Withdrawn |
NCT01546246 -
Water Method in Patients With Incomplete Colonoscopy
|
N/A | |
Withdrawn |
NCT01546220 -
Water Method in Elder Patients With Unsedated Colonoscopy
|
N/A |